Targeted News Service

MD Anderson Researchers Develop Novel Antibody-Toxin Conjugate
February 27, 2025

HOUSTON, Texas, Feb. 27 -- The University of Texas MD Anderson Cancer Center issued the following news release:

* * *

MD Anderson researchers develop novel antibody-toxin conjugate

New drug design prompts immune response rather than directly destroying cancer cells

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. Ac . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form